Biphasic Insulin Aspart 30/70: Pharmacokinetics and Pharmacodynamics Compared With Once-Daily Biphasic Human Insulin and Basal-Bolus Therapy
AUTOR(ES)
Heise, Tim
FONTE
American Diabetes Association
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2713630Documentos Relacionados
- Once-daily aminoglycoside therapy.
- Once-daily aminoglycoside therapy: potential ototoxicity.
- Once-daily aminoglycoside therapy: potential ototoxicity.
- Once-daily gentamicin therapy for experimental Escherichia coli meningitis.
- Pharmacokinetics of Tobramycin in Adults with Cystic Fibrosis: Implications for Once-Daily Administration
